Drug intelligence / Profile preview

Soyaklin Forte

Development stage
Unknown
Lead developer
Juvenor Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Soyaklin Forte is an oral phytomedicine developed by Juvenor Pharmaceuticals and marketed in collaboration with Piramal Enterprises. It is specifically formulated with soy isoflavones, which are naturally occurring phytoestrogens used to manage the climacteric symptoms associated with menopause, such as hot flashes, night sweats, and mood disturbances. The active components, primarily genistein and daidzein, function as selective estrogen receptor modulators (SERMs). These compounds exhibit a preferential binding affinity for estrogen receptor beta (ER-beta) over estrogen receptor alpha (ER-alpha), allowing them to exert estrogenic effects in tissues like bone and the cardiovascular system while potentially acting as antagonists or weak agonists in the breast and uterus. This profile makes it a common alternative to traditional hormone replacement therapy (HRT) for the prevention of postmenopausal osteoporosis and the relief of vasomotor symptoms.

Brand names
Soyaklin Forte
Other names
Soyaklin
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on Soyaklin Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soyaklin Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call